Expression of complement components of the alternative pathway by glioma cell lines

J Immunol. 1992 Aug 15;149(4):1381-7.

Abstract

Glioma cell lines express proteins of the complement alternative pathway, namely C3, factor B, factor H, and factor I. Secretion of these proteins was shown by a sensitive and specific ELISA. C3 and factor H were rapidly secreted by glioma cell line CB193 and reached a concentration of 140 ng/ml/10(6) cells after 72 h of culture. Factor B and factor I were secreted at a lower rate and reached concentrations of 25 and 15 ng/ml/10(6) cells, respectively. Western blot and immunoprecipitation experiments showed that secreted proteins were identical to the corresponding plasma proteins. For factor H, besides the well known 150-kDa species, an additional polypeptide of 45 kDa with factor H immunoreactivity was observed. This species corresponded to the N-terminal truncated form found in plasma. In preliminary experiments, we observed control of these syntheses by cytokines. IL-1 beta significantly increased C3 secretion, with no effect on factor H. Secretion of factor H was enhanced by IFN-gamma. These results show that a glioma cell line could be a useful tool to study complement biosynthesis by glial cells in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Complement C3 / metabolism*
  • Complement C3b Inactivator Proteins / genetics
  • Complement C3b Inactivator Proteins / metabolism*
  • Complement Factor B / genetics
  • Complement Factor B / metabolism*
  • Complement Factor H
  • Complement Factor I
  • Cytokines / pharmacology
  • Gene Expression / drug effects
  • Glioma / metabolism*
  • Humans
  • In Vitro Techniques
  • RNA, Messenger / genetics
  • Serine Endopeptidases / genetics
  • Serine Endopeptidases / metabolism*
  • Tumor Cells, Cultured

Substances

  • CFH protein, human
  • Complement C3
  • Complement C3b Inactivator Proteins
  • Cytokines
  • RNA, Messenger
  • Complement Factor H
  • Serine Endopeptidases
  • Complement Factor I
  • Complement Factor B